Medicinal Cannabis Industry Australia (MCIA) executive officer Patty Holmes reflects on a busy few days at ICBC in Berlin last week.
It was a busy few days for the Australian companies who were part of the MCIA delegation that attended ICBC.
Along with my colleague Rosemary Richards, MCIA hosted a delegation that included representatives from Biortica Agrimed, Cannatrek, ECS Botanics, OMG Pharma, Steritech, Zion Botanics, MediPharm Labs, MedTech Pharma and cannabis.org.au.
ICBC Berlin is one of the international cannabis events that focuses on the medicinal cannabis market as well as adult use, with a number of interesting speakers/topics specifically for the medical market in the program.
Representing MCIA, I was a panellist on the emerging legal cannabis markets session which was well attended.
The MCIA/Global Victoria booth was nestled between the Little Green Pharma, Apollo Green and OMG Pharma booths so there was a very Australian feel to our corner of the exhibition.
Events organised for the delegates included a private briefing session with Germany Trade and Invest (GTAI), Dentons and Cansativa GmbH.
Julia Albrecht from GTAI provided an overview of the German healthcare market with particular reference to medicinal cannabis, Malte Goetz presented the legal and regulatory framework for access to the market and Thiago Casar presented insights on how to successfully enter it.
We are very lucky to get access to such experienced and knowledgeable experts in their fields.
On the social side, a casual dinner reception for the delegation and a very well-attended wine reception at the MCIA/Global Victoria booth capped off a very productive few days in the German capital.
As the peak industry association for Australia’s licensed medicinal cannabis industry, MCIA continues to provide assistance and a platform for companies looking to interact with international markets.
